Ryan Haumschild, PharmD, MS, MBA: Thank you for this rich and informative discussion. Before we conclude, I’d like to get final thoughts from each of you. Dr Zeidan, I’ll start with you. What are your ...
Drs Fazal and Zeidan illustrate the roles and challenges of implementing oral therapies in MDS treatment management. Ryan Haumschild, PharmD, MS, MBA: Dr Fazal, when we’re looking at patients, there ...
CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough ...